PeptideMD Review

What PeptideMD charges

• Semaglutide: $249/mo — printed as 'Semaglutide Slim Start … $249 /month', with 2- and 3-month terms quoted lower on the same page; a plan term, not a different billing cycle
• Tirzepatide: $399/mo — printed as 'Tirzepatide Slim Pro … $399 /month', with 2- and 3-month terms quoted lower on the same page

PeptideMD also sells 7 compounds this site boards without publishing a price for them: Sermorelin, PT-141, Tesamorelin, GHK-Cu, MOTS-C (board ranks no provider), Semax (board ranks no provider) and Epitalon (board ranks no provider).

Two of its own pages, two prices, one tier

The homepage describes an entry tier as one targeted peptide on a thirty-day term. The pricing page describes its entry tier the same way, for the same one peptide over the same thirty days.

The two pages attach different figures to that identical description, and both were read on the same day. Nothing on either page explains the gap or marks one as superseded.

This review states the conflict and stops there. A buyer should ask which figure is current and get the answer in writing before paying anything.

A tier price cannot be a peptide price

The peptide tiers buy one peptide, unnamed. The molecule is chosen later, so the figure never attaches to sermorelin, PT-141, tesamorelin, GHK-Cu or anything else on the menu.

That makes cost-per-compound comparison impossible by design rather than by omission. Two buyers on the same tier can receive entirely different drugs for the same charge.

The GLP-1 lines are the exception. Semaglutide Slim Start and Tirzepatide Slim Pro are each priced against a named molecule on the seller's own page, so those figures mean something specific.

How the GLP-1 figures are stated

Both GLP-1 rates are stated per month, which makes the month the unit to compare against other sellers. Two- and three-month terms appear further down the same page.

Those longer terms change the length of the commitment rather than the billing period. A reader comparing monthly rates across sellers should hold the one-month line, not the term rate.

PeptideMD includes a baseline lab panel in its higher peptide tiers and says so on the page. Very few sellers here describe any lab work as part of what they charge.

Who you are contracting with is not stated

No corporate entity appears on the homepage, the pricing page, the terms or the privacy policy. A buyer signing up cannot name the company on the other side of the agreement.

The site describes the class of pharmacy that compounds its medication and says shipping is cold-chain, but never names the facility. That is a category, not something a reader can look up.

No list of states appears either, so coverage is settled during intake. Publishing a full pricing page rather than gating rates behind a form is still the better half of this record.

How we verified this

• Read the homepage and the pricing page in the same pass and recorded both entry-tier figures as printed, without choosing between them.
• Compared the tier descriptions word for word to confirm both describe one peptide over a thirty-day term before recording the difference as a conflict.
• Recorded price rows only for the two named GLP-1 medications, because a tier figure buys an unnamed peptide and cannot honestly attach to any molecule.
• Recorded the billing period printed beside each GLP-1 figure, and noted the two- and three-month options as plan terms rather than different billing cycles.
• Read the homepage, pricing page, terms and privacy policy for a corporate entity and for a named dispensing facility, and recorded what each page states instead.